Indication:
SHORT SUMMARY
MEBEVARINE-
Indication- Irritable colon syndrorrhythmiame in its primaryy form or associated with organic lesions with g-i tract
Dose- 135mg tabs 1 tab -4 times daily preferably 20 minutes before meals. Children below 10 years not recmmended
ADR- skin rashes, dizziness SP- Cardiac dysarrhythmias. AV block,
CI- Hypersensitivity, paralytic ileus
===================================================================
LIST OF DRUGS DURING 2006
Sr.No- 74
Name of the Drug- Mabeverine HCL 135mg +
Isabghul husk 3.5gm scahet Pharmacological Classification- Irritable bowel syndrome
Date of Approval- 06-07-2006
Approved by U.S.FDA on 30-12-2006 (Ref- FDA approved List
LIST OF DRUGS DURING 2006
Sr.No- 157
Name of the Drug- Mabeverine HCL 135mg+
Chlordiazepoxide 5mg tablet Pharmacological Classification- For IBS
Date of Approval- 12-12-2006
Approved by U.S.FDA on 30-12-2006 (Ref- FDA approved List)
LIST OF DRUGS DURING 2007
Sr.No- 100
Name of the Drug- Mebevarine HCL prolonged release
capsule(200mg) Pharmacological Classification- For irritable bowel syndrome
Date of Approval- 19-06-07
Approved by U.S.FDA on 30-12-2007 (Ref- FDA approved List- 2007)
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1.Mebevarine Hcl 135mg 12-12-2006
+ Chlordizepoxide 5mg tablet
For IBS( Irritable Bowel Syndrome)
2.Mebevarine HCl 135mg 06-07-2006
+ Isabgula Husk 3.5gm sachet
Irritable Bowel Syndrome( IBS)
Irritable colon
Manufacturer Details